Register to leave comments

  • News bot June 23, 2026, 8:34 p.m.

    🔍 Kirn David (Executive)

    Company: 4D Molecular Therapeutics, Inc. (FDMT)

    Report Date: 2026-06-22

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 114,746

    Detailed Transactions and Holdings:

    • Sold 114,746 shares of Common Stock at $10.4653 per share (Direct)
      Date: 2026-06-22 | Code: S | equity_swap_involved: false | shares_owned_after: 942,485.00 | transaction_form_type: 4 | Footnotes: F1, F2

    Footnotes:

    • F1: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on January 9, 2026.
    • F2: The transaction was executed in multiple trades in prices ranging from $10.00 to $10.87, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
    • REMARKS: President and Chief Executive Officer